Background-The prevalence of native coronary chronic total occlusions (CTOs) after coronary artery bypass grafts (CABGs) is higher than in non-CABG population. We examined outcomes of CTO percutaneous coronary intervention (PCI) post-CABG versus without CABG. Then, we looked at feasibility and outcomes of retrograde CTO PCI via patent or occluded saphenous vein graft. Methods and Results-We compared patient and procedural characteristics of 470 CTO cases treated from January 2010 to December 2015 depending on history of CABG. We assessed major adverse cardiac events, including cardiac death, myocardial infarction, ischemia-driven target-vessel revascularization, or reocclusion 1 year after successful CTO PCI in patients treated before February 2015. Post-CABG patients (175 cases) had a higher J-CTO score (2.5 versus 2.1; P=0.002). In-hospital complications were similar, although the incidence of contrast-induced nephropathy was higher in post-CABG patients (4.6% versus 1%; P=0.01). With multivariable analysis, post-CABG status was associated with higher incidence of 1-year major adverse cardiac event (hazards ratio=2.2; P=0.02). As a second level analysis, we looked at the feasibility and safety of CTO PCI via saphenous vein grafts (19% of post-CABG cases) versus collateral channels (36%) versus with an antegrade-only approach (45%), and assessed short-term outcomes and complications. High success was achieved in the saphenous vein graft group. In-hospital events were similar in the 3 groups. Conclusions-Post-CABG CTO PCI is associated with similar high success and low complications compared with CTO PCI in patients who never had CABG. However, it is associated with higher recurrent events at 1 year. To achieve high success rate, use of saphenous vein grafts as retrograde conduits seems to be safe and effective. (Circ Cardiovasc Interv. 2016;9:e003515.
A lthough coronary artery bypass graft (CABG) surgery was associated with improved longer-term outcomes in several randomized trials compared with percutaneous coronary intervention (PCI) with drug-eluting stents for the treatment of multivessel coronary artery disease, it remains associated with inherent problems. First, even after 1 year, up to 40% of saphenous vein grafts (SVGs) will be occluded. 1 More commonly, 40% to 50% of SVGs will be diseased or occluded in the first 10 years. 2 Second, CABG by itself escalates progression of atherosclerosis or thrombosis in bypassed native coronary arteries 3 ; 43% of bypassed native coronary arteries will develop chronic total occlusions (CTOs) as early as 1 year after CABG. 4 As a result, the prevalence of native artery CTO in patients undergoing coronary angiography reaches 54% in the post-CABG population, higher than in patients without CABG. 5 In summary, when SVGs become diseased or occluded, the whole native coronary tree has sustained substantial changes and has become more difficult to treat. Unfortunately, SVG PCI, although associated with fair results with drug-eluting stent in less diseased grafts, 6 is associated with poor long-term outcomes when performed on occluded, degenerated grafts. 7, 8 To achieve native coronary rather than SVG revascularization, mastering CTO PCI skills becomes therefore essential. Histologically, native coronary CTO lesions of patients post-CABG are more extensively calcified 9 and therefore offer additional challenges that may also affect long-term outcomes. Only few studies have evaluated outcomes following CTO PCI in post-CABG patients, [10] [11] [12] and none reported longer-term outcomes.
Over the past decade, the techniques of CTO PCI have evolved into a hybrid approach 13 with high success rate. Based on the proposed algorithm, retrograde techniques should be utilized in cases of ambiguity of proximal cap, presence of disease or major bifurcation at the distal cap, and appropriate interventional collaterals. These collateral channels (CCs) can be septal, epicardial connections but also can be CABGs (either venous or arterial). 14 
CTO PCI in Post-CABG Patients
There is only limited data on the safety and efficacy of retrograde CTO PCI via SVG, 11, 15 especially when using occluded SVGs as a retrograde conduit to deliver gear to the distal cap. In this singleprogram experience, we report our short-and longer-term results of CTO PCI in 2 different cohorts of patients: post-CABG versus non-CABG over a 5-year period. Then, among post-CABG CTO cases, we examined the feasibility and complications of CTO PCI using patent or occluded SVGs as retrograde conduits to the native CTO vessel in comparison with all other techniques.
Methods

Study Population, Variables, and Outcomes Definition
A total of 470 consecutive CTO PCI procedures were performed from January 2010 to December 2015 in the Quebec Heart and Lung Institute hybrid CTO program, including 175 (35.2%) in post-CABG patients. For all study patients, baseline, procedural, and hospitalization data were prospectively collected and entered into a dedicated database. We assessed technical success of the procedure, defined as the ability to open the CTO, with a final TIMI 3 flow after stenting. Other factors such as contrast load, radiation, and procedure time were also recorded. Short-term event assessment focused on the in-hospital period following CTO PCI, and included death, type 4A myocardial infarction (MI), 16 stroke, cardiac tamponade, major bleeding (as per BARC criteria), 17 major vascular complications, and contrast-induced nephropathy. Longer-term events, such as cardiac death, MI, target-vessel revascularization, or target-vessel reocclusion, all considered major adverse cardiac events (MACE), were collected in patients treated successfully before February 2015 if patients were readmitted in our institution. Otherwise, they were systematically contacted by telephone 12 to 18 months after their PCI by a trained research assistant who was not aware of procedural data. Data collection and follow-up was approved by our institutional review committee as part of the Recherche Évaluative en Cardiologie InTervenionnelle registry and subjects provided signed informed consent. Otherwise, the hospital director of professional services provided written authorization to review the angiographies and collect anonymized and follow-up data.
Study Groups of Interest
We first divided the study sample into 2 groups: post-CABG patients versus those who never had bypass surgery. The former group was further classified into 3 subgroups: when a retrograde approach was performed using an SVG, when a retrograde technique was used via a CC, and when an antegrade-only approach was used.
WHAT IS KNOWN
• Coronary artery bypass graft (CABG) surgery increases the prevalence of native coronary artery chronic total occlusions (CTOs).
• Treatment of CTO lesions remains extremely challenging and long-term outcomes are unknown.
WHAT THE STUDY ADDS
• The difficulty of CTO percutaneous coronary intervention (PCI) in post-CABG patients has a similar success rate to CTO PCI in non-CABG patients.
• Post-CABG patients are at higher risk of recurrent events after CTO PCI than patients who never had bypass surgery.
• Diseased or occluded saphenous vein grafts are excellent retrograde conduits for CTO PCI of native coronary arteries. Retrograde left circumflex (LCx) chronic total occlusion (CTO) percutaneous coronary intervention (PCI) through an occluded saphenous vein graft (SVG) rather than an epicardial collateral channels. A, SVG to an obtuse marginal (OM)1 that has been documented occluded for 2 years. A stump is visible (black arrow). Surgical clips are visualized (white arrows). B, A Pilot 200 guidewire is advanced into the occluded graft, with the trajectory guided by surgical clips. C, The tip of the guidewire is now in the mid portion of the graft. D, Injection from the left main reveals the LCx CTO with epicardial collaterals from a diagonal branch (white arrows). The tip of the guidewire is close to the OM (black arrow). E, Contrast staining in the graft from a distal Corsair injection of contrast (white arrows). Successful crossing into the OM (black arrow). F, Subsequent advancement of the Corsair into the OM (black arrow). Very acute angle to the proximal LCx target CTO (white arrow). G, A Miracle Bro 12 guidewire (black arrow) shaped with a long and round curve is used to track into the proximal OM segment, and provides enough support to advance the microcatheter (H) while preventing wire prolapse into the distal OM. A distal graft perforation with staining extending beyond the lateral borders of the SVG is visualized (white arrow). I, Reverse-CART. J, Final result after drug-eluting stent implantation and coil delivery into the SVG (black arrow) that sealed the perforation. CART indicates controlled antegrade and retrograde subintimal tracking. 
SVG Crossing for Retrograde CTO PCI in Post-CABG Patient
SVGs were considered good potential conduit for a retrograde procedure when they were highly degenerated but patent, therefore at high risk for subsequent occlusion if treated with PCI. 7, 15, 18 Also, SVGs presenting with recurrent in-stent restenosis were considered appropriate subset to consider treatment of the native artery CTO rather than the graft. Finally, occluded SVGs were also good conduits as long as a proximal tapered stump could be identified ( Figure 1 ).
Study Outcomes of Interest
We assessed technical success, contrast volume, radiation, in-hospital complications (death, type 4A MI, stroke, cardiac tamponade, major bleeding, major vascular complications, and contrast-induced nephropathy), and longer-term MACE following CTO PCI based on previous CABG history or not. We then examined feasibility, technical aspects, success, contrast volume, radiation, in-hospital complications of CTO PCI utilizing patent or occluded SVGs in comparison with all other retrograde channels crossing, and all antegrade approaches.
Statistical Analysis
Continuous variables were expressed as mean values and SD and binary variables as percentages. Pairwise comparisons were performed using the χ 2 test or Fisher exact test for discrete data, and t test (with 2 groups) or ANOVA (with 3 groups) for continuous variables. Time-to-event analysis was done for longer-term outcomes up to the median follow-up duration (365 days), and the log-rank test used to compare groups. Cox proportional hazards models were used to assess the impact of the post-CABG status using a priori selected variables known to potentially influence outcomes. A P<0.05 was considered statistically significant. No adjustments were made for multiple comparisons. All analyses were conducted using SAS 9.3 (SAS Institute, Cary, NC).
Results
Comparison of Post-CABG Versus Non-CABG CTO Cases
Baseline Clinical, Angiographic Characteristics, and Procedural Outcomes
Baseline clinical characteristics and procedural data of CTO cases treated in post-CABG versus non-CABG populations are presented in Table 1 . Post-CABG patients were significantly older (P<0.0001) and were more likely to be males (P=0.01), diabetics (P<0.0001), hypertensives (P<0.0001), nonsmokers Overall, CTO lesions in post-CABG cohort were more complex than in non-CABG: longer (>20 mm; P=0.05 and >40 mm; P=0.0001), more angulated (<0.0001), more calcified (<0.0001), and more often had blunt proximal cap (P<0.07) and proximal cap ambiguity (P=0.003). Finally, post-CABG CTOs had a higher mean J-CTO score (2.5±1.3 versus 2.1±1.2; P=0.002) and more frequently very difficult lesions (J-CTO ≥3 in 54% versus 37%; P=0.0003). There were significantly more dominant septal CCs in the non-CABG, while there were more dominant epicardial CCs in the post-CABG cohorts (P<0.0001). CTO was more often recanalized with antegrade wire escalation technique in the non-CABG group and with retrograde dissection and reentry in the post-CABG group.
Generally, post-CABG cases took longer time (172 versus 129 minutes; P<0.0001), required more radiation (P=0.002), fluoroscopy time (73 versus 53 minutes; P<0.0001), contrast volume (346 versus 306 cc; P=0.004) than non-CABG cases.
Despite some significant differences between post-CABG and non-CABG CTO cases, the final technical success in our CTO program did not differ between these 2 distinct cohorts of CTO patients and was 90% and 93% (P=0.32), respectively.
Short-Term Adverse Events
Complications are presented in Table 2 . We did not observe any significant difference between the two groups, besides a higher incidence of contrast-induced nephropathy in post-CABG patients (4.6 versus 1.0%; P=0.01). Concurrently, the latter group had significantly higher baseline creatinine and procedural contrast volume (Table 3) . No patient required dialysis.
Longer-Term Outcomes
By univariable analysis, treatment of post-CABG CTOs was associated with worse longer-term outcomes, including a higher cardiac death (Figure 2A ) and a higher incidence of MACE ( Figure 2B ), although 85% remained event free after a median follow-up of 1 year. Events were largely driven by target-vessel revascularization. When controlling for potential confounding factors, post-CABG status was still associated with MACE ( Table 4 ). Treatment of an in-stent CTO was also associated with MACE.
Comparison of Post-CABG CTO Cases Performed via SVG Conduits Versus All Other Retrograde or Antegrade Pathways
Baseline Clinical, Angiographic Characteristics, and Procedural Outcomes
In the 175 post-CABG cases, an antegrade approach was used in 78 (45%) cases, a retrograde approach using CC in 63 (36%) and a retrograde approach using an SVG in 34 (19%; Table 5 ). There were no significant differences in baseline patient characteristics between these 3 groups, except for the fact that more CTOs were treated ad hoc after the diagnostic coronary angiography from the SVG, as a result of acute graft failure. Meanwhile there were some significant differences in lesion characteristics. CTO segments treated with a retrograde approach (via SVG or via CC) were longer (P<0.0003), more angulated (P=0.001), more often had blunt proximal cap (P<0.0001), proximal cap ambiguity (P<0.0001), and interventional collaterals (P<0.0001) when compared with the antegrade group.
Overall, CTOs treated from a retrograde approach were more complex than when treated with an antegrade-only approach, with mean J-CTO 2.9±1.1 and 3.1±1.0 versus 1.7±1.2 (P<0.0001), respectively. The prevalence of difficult CTO lesions (J-CTO ≥3) was higher in the 2 retrograde groups than in the antegrade group (68% and 76% versus 31%; P<0.0001). Dominant collaterals were distributed as follows: more dominant septals in the septal and epicardial CC retrograde group, more dominant epicardial CC in the antegrade group, and more dominant SVG flow in the SVG group (P=0.05). Dissection and reentry techniques were more frequently utilized in the 2 retrograde groups than in the antegrade group (P=0.0001). Retrograde success rate was higher using an SVG than a CC. Radiation dose, fluoroscopic time, contrast use, procedure duration were all lower in the antegrade group, followed by the retrograde via SVG group and finally by all other retrograde approaches (P<0.0001 for all, but P=0.01 for contrast use).
Detailed Analysis of 34 Post-CABG Retrograde CTO Cases Performed via SVG Conduits
A total of 19 SVGs (56%) were completely occluded before the retrograde attempt, and the oldest occlusion was 13 years old ( Table 6 ). There were 8 acutely occluded grafts; these cases were all performed ad hoc. In 13 cases (38%), we used mother-and-child technique to increase stability and support for the guiding catheter in the SVG. In all cases, the child catheter entered to half of the SVG length. Three SVGs needed to be predilated with a balloon to continue CTO PCI. One patient likely presented distal embolization that resulted in a post-PCI MI, although it was not visible angiographically. It took 8±10 minutes to cross an SVG with a guidewire. In the first 2 cases, no coil was delivered in the remaining patent graft, resulting in subsequent native stents occlusion and graft occlusion. Thereafter, we decided to coil patent SVGs with TIMI 2 or 3 flow. We did not coil SVG if TIMI score was ≤1 on the final angiography of vein graft. As a result, we delivered coils in 15 cases (44%), when the residual competitive flow from the SVG was perceived to be strong enough to potentially compromise flow and outcomes of the newly open native vessel.
Short-Term Adverse Events
We did not observe any significant difference between the 3 groups. In the retrograde CTO cases performed via SVG conduit group, 1 patient presented cardiac tamponade resulting from SVG perforation at the site of the distal anastomosis. It was successfully drained. This CTO PCI procedure failed.
There was one other case of SVG perforation, which remained stable as we continued the CTO PCI procedure, without clinical and echocardiographical evidence of tamponade. This SVG was coiled after CTO PCI was completed. One patient died of an antegrade perforation of the CTO with intramuscular bleeding, leading to intractable ventricular tachycardia. This event was unrelated to the fact that we used a patent SVG to an left anterior descending (Table 7 ).
Discussion
In this study, we found that, despite significant differences between post-CABG and non-CABG native coronary CTO cases, the final technical success in our CTO program did not differ between these 2 distinct cohorts of CTO patients (90% and 93%, respectively). This finding could be explained by fast development in techniques and dedicated equipment in CTO PCI. Although CTO PCI in post-CABG patients is not associated with a higher short-term risk, besides contrast-induced nephropathy, longer-term outcomes are slightly worse than when patients never had bypass surgery. We also found that selected SVGs, either patent or occluded, can become very effective conduits for retrograde CTO PCI, and their use is associated with a very high final technical success and low complication. When we compared our single center CTO program data to those from Europe, Japan, and the USA [10] [11] [12] 19, 20 (Table 8) , we found that our study population had one of the highest number of post-CABG CTO cases, comparable only to 1 American multicenter study of 2013 by Michael et al. 20 We used a retrograde approach in post-CABG patients more frequently than anyone else. In the same post-CABG cohort, we performed retrograde CTO PCI via SVG more often than others. The reason why the proportion of retrograde cases is higher than other series is unknown. As displayed in Table 5 , cases treated from the retrograde approach appeared to have had many justifying factors to proceed the way we selected; they had a higher proportion of proximal cap ambiguity, longer lesions or bifurcation at the distal cap, and high J-CTO scores. We can also speculate that our success with SVG utilization may have lowered our threshold to consider using them earlier in the post-CABG CTO PCI cases. We have shown the highest technical success both in overall CTO population, as well as in post-CABG CTO cases. However, this came at the cost of higher fluoroscopy time and contrast use comparing with other studies. This may also explain a higher incidence of contrast-induced nephropathy in post-CABG patients.
Our study is the first to assess the impact of previous CABG on longer-term outcomes specifically. We found that those patients were at a higher risk of MACE at 1 year, largely driven by benign target-vessel revascularization, but also with cardiac mortality compared with patients who never had bypass. However, 85% of these patients still remained free of events, which is reassuring in terms of the longevity of CTO PCI in this higher-complexity population. We also report the highest series of retrograde procedures performed from SVGs. Those procedures were overall not at a higher risk than other approaches in post-CABG patients. Interestingly, almost a quarter of CTO cases in the SVG subgroup were performed in ad hoc scenario where patients had acute graft failure and represented an interesting subset of patients in whom non-CTO operators would have likely chosen to intervene on the occluded SVG. However, in the setting of ACS, we took a decision to open a native artery CTO instead of dealing with the culprit thrombosed and diseased SVG . We think that the current body of evidence supports this decision, 7 with a recent analysis from Brilakis et al 21 done in a large cohort of post-CABG patients from the US Veterans Affairs program that showed improved outcomes when native coronary arteries are treated instead of SVGs. While in our CTO program we try to avoid ad hoc CTO PCI and prefer to prepare for each case with a detailed strategic plan, an acute occlusion of an SVG documented in a center with a hybrid CTO program may be a good indication to open the native artery CTO 15 once TIMI 3 flow in the graft is restored.
We showed that the retrograde approach for native artery CTO PCI via an occluded or patent SVG is a safe and feasible option and should be considered when the anatomy suggests that the retrograde approach would be more effective. In the majority of cases, SVG crossing took <10 minutes. Possible complications that could happen during SVG crossing may potentially include those encountered during SVG interventions, ie, perforation of old, degenerated and calcified SVG with tamponade, slow or no-reflow, etc. We had a small perforation of SVG in 1 case. Because the patient was stable, we continued the procedure and after opening the CTO we coiled the graft with excellent procedural result and at the same time effective management of the perforation. However, we had a distal SVG perforation in a previously occluded graft that resulted in a tamponade, underlying the fact that crossing an occluded SVG deserves similar care to crossing CCs. It is worth mentioning that we never used occluded SVGs without a stump. In fact, we think that stumpless SVG occlusion is a relative contraindication to SVG utilization. Overall, CTO operators should search for occluded or diseased SVG in post-CABG patients that may be excellent conduits to successful retrograde CTO, when indicated. Indeed, compared with other retrograde approaches, use of SVG reduced radiation, contrast volume, fluoroscopic and procedural time and was associated with high success and similar complications ( Tables 5 and 7) .
Our study has limitations. First, it is a single-program series, which may be influenced by local operators' volume, skills, and experience. Nevertheless, we knew SVGs had been used as retrograde conduits to native coronary CTO PCI by other operators, and yet no data were available on the effectiveness of the method. Second, although this series constitute the largest study to date on the subject of retrograde SVG crossing per se, it is still limited by the sample size. Third, no angiographic core laboratory was used. However, most observational CTO PCI studies do not report core laboratory assessments. Finally, although our preliminary experience suggests that coiling patent SVG may prevent competitive flow and subsequent native stent thrombosis after successful CTO PCI, our sample size is too small to perform a detailed comparative assessment with a more observational approach. Further studies are needed to support this strategy. Continuous data are presented as mean±SD or median and (25th-75th percentiles). CABG indicates coronary artery bypass grafting; CTO, chronic total occlusion; J-CTO, Japanese-Chronic Total Occlusion; MC, multicenter; n/a, data not available; PCI, percutaneous coronary intervention; retro, retrograde approach; SC, single center; and TS, technical success.
*No data available for post-CABG CTO cohort; data given for overall CTO population in the study. †From 2006 to 2011. ‡Data presented for retrograde approach cohort only. §Out of 1395 patients performed via retrograde approach.
